VentriPoint Diagnostics Ltd
XTSX:VPT

Watchlist Manager
VentriPoint Diagnostics Ltd Logo
VentriPoint Diagnostics Ltd
XTSX:VPT
Watchlist
Price: 0.125 CAD
Market Cap: CA$21m

Net Margin

-2 312.1%
Current
Improving
by 4 824.7%
vs 3-y average of -7 136.8%

Net Margin shows how much profit a company keeps from each dollar of sales after all expenses, including taxes and interest. It reflects the company`s overall profitability.

Net Margin
-2 312.1%
=
Net Income
CA$-4.1m
/
Revenue
CA$175.6k

Net Margin shows how much profit a company keeps from each dollar of sales after all expenses, including taxes and interest. It reflects the company`s overall profitability.

Net Margin
-2 312.1%
=
Net Income
CA$-4.1m
/
Revenue
CA$175.6k

Peer Comparison

Country Company Market Cap Net
Margin
CA
VentriPoint Diagnostics Ltd
XTSX:VPT
21m CAD
Loading...
US
Intuitive Surgical Inc
NASDAQ:ISRG
188.3B USD
Loading...
US
Abbott Laboratories
NYSE:ABT
187.1B USD
Loading...
US
Boston Scientific Corp
NYSE:BSX
138.8B USD
Loading...
US
Stryker Corp
NYSE:SYK
135B USD
Loading...
IE
Medtronic PLC
NYSE:MDT
128.9B USD
Loading...
US
Becton Dickinson and Co
NYSE:BDX
59.2B USD
Loading...
DE
Siemens Healthineers AG
XETRA:SHL
47.5B EUR
Loading...
US
IDEXX Laboratories Inc
NASDAQ:IDXX
55.6B USD
Loading...
US
Edwards Lifesciences Corp
NYSE:EW
48.5B USD
Loading...
US
Resmed Inc
NYSE:RMD
37.6B USD
Loading...

Market Distribution

Lower than 91% of companies in Canada
Percentile
9th
Based on 4 909 companies
9th percentile
-2 312.1%
Low
-9 940 586.9% — -85.9%
Typical Range
-85.9% — 5.5%
High
5.5% — 60 777.6%
Distribution Statistics
Canada
Min -9 940 586.9%
30th Percentile -85.9%
Median -7.8%
70th Percentile 5.5%
Max 60 777.6%

VentriPoint Diagnostics Ltd
Glance View

Market Cap
21m CAD
Industry
Health Care

VentriPoint Diagnostics Ltd. is a medical device company, which engages in the development and commercialization of diagnostic tools that monitor patients with heart disease. The company is headquartered in North York, Ontario. The company went IPO on 2005-11-09. The firm offers Ventripoint Medical System (VMS) equipment. The firm's VMS+ is a diagnostic aid, which is developed to provide a point-of care solution to communicate the heart's structure and function without the need for magnetic resonance imaging (MRI). Its VMS+ is designed to create a three-dimensional (3D) model of the heart from a two-dimensional (2D) echocardiogram and allows cardiac metrics on all four chambers of the heart within minutes. The firm enables VMS+ software to be installed on any personal workstation. The Company’s Knowledge Based Reconstruction (KBR) enables to construct a 3D model of the heart and calculates volumes and ejection fractions for all chambers. The firm has not generated any revenues.

VPT Intrinsic Value
HIDDEN
Show
What is Net Margin?
Net Margin shows how much profit a company keeps from each dollar of sales after all expenses, including taxes and interest. It reflects the company`s overall profitability.
How is Net Margin calculated?

Net Margin is calculated by dividing the Net Income by the Revenue.

Net Margin
-2 312.1%
=
Net Income
CA$-4.1m
/
Revenue
CA$175.6k
What is VentriPoint Diagnostics Ltd's current Net Margin?

The current Net Margin for VentriPoint Diagnostics Ltd is -2 312.1%, which is above its 3-year median of -7 136.8%.

How has Net Margin changed over time?

Over the last 3 years, VentriPoint Diagnostics Ltd’s Net Margin has increased from -12 132.4% to -2 312.1%. During this period, it reached a low of -13 201.1% on Sep 30, 2023 and a high of -2 312.1% on Oct 30, 2025.

Back to Top